To answer this question, I of course asked different AIs what the answer would be. Their responses: ChatGPT. In 2025, AI will significantly enhance healthcare by improving diagnostic accuracy, such as detecting early-stage cancers through tools like AI-enhanced mammograms and identifying retinal diseases via AI-analyzed optical scans. Personalized medicine will advance as AI tools like…
There’s a new health innovation law firm in town! Rebecca Gwilt & Kaitlyn O’Connor have started Elevare Law to help health tech companies. We spent a little time talking about the new firm and who it’s going to work with, and a lot about the different legal and regulatory challenges facing digital health companies. Deep…
Patients enrolled in a pilot program experienced a significant clinical improvement, including an increase in achieving medication optimization, health system says
New office will oversee the design, development, delivery, and operation of CMS digital products and platforms
With the incoming Trump administration and Republican-led Congress looking to ways to reduce federal spending, a new KFF Health Tracking Poll finds that the Medicare and Medicaid programs remain broadly popular, and more people favor more spending on those programs than less spending. About eight in 10 Americans overall view Medicare (82%) and Medicaid (77%)…More
Healthcare interoperability isn’t an abstract concept; it’s about human connection, building trust and easing burden on patients and their care providers. The post Trust, Technology and the Future of Interoperability: Solving Problems That Impact Real Lives appeared first on MedCity News.
As bird flu continues to spread among animals in the U.S., KFF’s Tracking Poll on Health Information and Trust finds that the public is more concerned about its impact on food prices than potential health impacts. Trust in the CDC to provide information on bird flu is also divided along partisan lines, and a large…
BridgeBio Pharma claims its drug, Attruby, has an edge over a Pfizer drug as a treatment for cardiomyopathy caused by transthyretin-mediated amyloidosis. But new competition to both products could come soon from Alnylam Pharmaceuticals, now set to receive an FDA decision in this indication by late March. The post FDA Nod for BridgeBio Brings New…
[Sponsored] A recent webinar, sponsored by Verato, offered insights from executives at SCAN Health Plan and the Alliance of Community Health Plans on a wide range of tech challenges in healthcare from fragmented data to technology architecture to patient identity. The post How Payers and Health Plans Think of Identity and the Risks of Fragmented…
September 8-14 is Environmental Services Week, a week where we recognize and celebrate all our EVS professionals. We aim to foster a culture of appreciation for all the hardworking people that support Crothall Healthcare’s operations. This week, however, we are shining a spotlight on our EVS team members at facilities across the nation—their hard work…